Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis

著者: Benjamin Ungar, Ana B. Pavel, Randall Li, Grace W. Kimmel, John K Nia, Peter W. Hashim, Hee Jin Kim, Margot Chima, Anjali S. Vekaria, Yeriel Estrada, Hui Xu, Xiangyu Peng, Giselle Singer, Danielle Baum, Yasaman Mansouri, Mark Taliercio, Emma Guttman‐Yassky - Journal of Allergy and Clinical Immunology 2020 被引用: 123